Thursday - January 9, 2025
FTC Statement on Appellate Court Decision Ordering Delisting of Teva Inhaler Patents
December 20, 2024
WASHINGTON, Dec. 20 -- The Federal Trade Commission issued the following news release:

Today, the U.S. Court of Appeals for the Federal Circuit affirmed a lower district court order against pharmaceutical maker Teva requiring the drugmaker to delist several asthma inhaler patents from the Food and Drug Administration's (FDA) Orange Book.

The appellate court order stems from a case brought by Teva against drugmaker Amneal after Amneal sought FDA approval to bring a . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products